Is the rise in drug stock prices sustainable?


Fine run: Pharmaniaga has risen by as much as 530% from its March-MCO low of 88 sen in the recent pharmaceutical stock play.

AFTER going through a sustained phase of accumulation, following the announcement of the movement control order (MCO), pharmaceutical stocks saw a sudden surge in prices during the week.

They have seen strong gains after traders and investors drove up their prices in expectations of a Covid-19 vaccine that would be available in the near future.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Pharmaniaga , Duopharma , MCO , Apex , Kotra Industries ,

   

Next In Business News

Wall St set to open higher on tech boost, PCE data
US inflation rises in line with expectations in March
Gamuda Land announces retail partners for Gamuda Gardens
YNH reaffirms bondholders with remedied technical defaults
Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih

Others Also Read